Mega Lifesciences PCL (BKK:MEGA) Change In Receivables : ฿115 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Change In Receivables?

Mega Lifesciences PCL's change in receivables for the quarter that ended in Mar. 2024 was ฿391 Mil. It means Mega Lifesciences PCL's Accounts Receivable declined by ฿391 Mil from Dec. 2023 to Mar. 2024 .

Mega Lifesciences PCL's change in receivables for the fiscal year that ended in Dec. 2023 was ฿-324 Mil. It means Mega Lifesciences PCL's Accounts Receivable increased by ฿324 Mil from Dec. 2022 to Dec. 2023 .

Mega Lifesciences PCL's Accounts Receivable for the quarter that ended in Mar. 2024 was ฿3,007 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mega Lifesciences PCL's Days Sales Outstanding for the three months ended in Mar. 2024 was 73.51.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mega Lifesciences PCL's liquidation value for the three months ended in Mar. 2024 was ฿2,717 Mil.

Mega Lifesciences PCL Change In Receivables Historical Data

The historical data trend for Mega Lifesciences PCL's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Change In Receivables Chart

Mega Lifesciences PCL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-160.86

65.01

-47.35

-678.76

-323.90

Mega Lifesciences PCL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-48.35	-202.04	-164.72	91.22	390.90

Mega Lifesciences PCL Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿115 Mil.

Mega Lifesciences PCL (BKK:MEGA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Mega Lifesciences PCL's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3006.84	/	3732.661	*	91
=	73.51

2. In Ben Graham's calculation of liquidation value, Mega Lifesciences PCL's accounts receivable are only considered to be worth 75% of book value:

Mega Lifesciences PCL's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3315.124	-	4414.605	+	0.75 * 3006.84	+	0.5 * 3123.205
=	2,717

Mega Lifesciences PCL Change In Receivables Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL (BKK:MEGA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea,Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods as well as the provides distribution services relating to such products. The company's products portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purpose and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL (BKK:MEGA) Headlines

No Headlines